Tue, June 22, 2021
Mon, June 21, 2021
Sun, June 20, 2021
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021
Wed, June 9, 2021
Tue, June 8, 2021

Joseph Schwartz Maintained (ASND) at Buy with Decreased Target to $181 on, Jun 14th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-181-on-jun-14th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Schwartz of SVB Leerink, Maintained "Ascendis Pharma A/S" (ASND) at Buy with Decreased Target from $191 to $181 on, Jun 14th, 2021.

Joseph has made no other calls on ASND in the last 4 months.



There are 3 other peers that have a rating on ASND. Out of the 3 peers that are also analyzing ASND, 1 agrees with Joseph's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, March 30th, 2021


These are the ratings of the 2 analyists that currently disagree with Joseph


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $196 on, Tuesday, June 1st, 2021
  • Tiago Fauth of "Credit Suisse" Maintained at Buy with Increased Target to $178 on, Friday, May 28th, 2021

Publication Contributing Sources